AI project overview
Condensed summary based on project data
<p><span style="font-size:18pt"><span style="font-family:Calibri,sans-serif"><strong>Avant Devices, S.L. — Crowdfunding Investor Memo</strong></span></span></p>
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><em>Avant Devices makes a kit that turns an ordinary manual wheelchair into an electric, multi-terrain one, aimed at people with reduced mobility who want to keep their own chair.</em></span></span></p>
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong>Sector: </strong>Medtech / assistive mobility hardware · <strong>Stage: </strong>Early / pre-seed (pre-revenue) · <strong>HQ: </strong>Murcia, Spain · <strong>Raise: </strong>€15k min – €215k max (KIIS); campaign shows a €260k total round</span></span></p>
<h1><span style="font-size:14pt"><span style="font-family:Calibri,sans-serif">Snapshot</span></span></h1>
<table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:602px">
<tbody>
<tr>
<td style="background-color:#f0f4f8; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:200px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">1 · Is the price fair? 💶</span></strong></span></span></p>
</td>
<td style="background-color:#f0f4f8; border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:402px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">Insufficient comparables to assess.</span></strong><span style="color:black"> No independent priced rounds or recorded exits for wheelchair power-assist / conversion-kit startups at this stage and geography could be found, so the ~€1.05–1.10M pre-money cannot be scored fair or unfair. See the questions section.</span></span></span></p>
</td>
</tr>
<tr>
<td style="background-color:#f0f4f8; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:200px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">2 · Can they reach an exit stage? ⭐</span></strong></span></span></p>
</td>
<td style="background-color:#faece7; border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:402px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">AI SCORE 61 / 100 — Average. </span></strong></span></span><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><span style="color:black">Strongest evidenced precondition: a large, independently corroborated market with a working, multi-terrain prototype the company reports it has field-tested. Biggest gap: no revenue, no units sold, and certification not yet achieved.</span></span></span></p>
</td>
</tr>
<tr>
<td style="background-color:#f0f4f8; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:200px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">3 · If they do, what could it pay? 🎯</span></strong></span></span></p>
</td>
<td style="background-color:#f0f4f8; border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:402px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">Target 15–20x over 7–10 years</span></strong><span style="color:black"> (stage-standard for a pre-seed company — the company did not state its own target). If an exit is reached, illustratively <strong>roughly 6x–15x</strong> before fees and future dilution — the company's own 2029 revenue plan (€3.87M) times the 2–4x revenue range typical for hardware/medical-device acquisitions, set against the disclosed ~€1.05–1.31M entry valuation. No deal-specific comparables were found (market context: Mordor Intelligence, Grand View Research). This is an illustration, not a forecast.</span></span></span></p>
</td>
</tr>
</tbody>
</table>
<p> </p>
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong>How to read the score</strong></span></span></p>
<table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:602px">
<tbody>
<tr>
<td style="background-color:#d9ebc2; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:173px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">85–100 · Excellent</span></strong></span></span></p>
</td>
<td style="background-color:white; border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:428px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><span style="color:black">All key preconditions for reaching an exit stage are evidenced and strong — rare at this stage</span></span></span></p>
</td>
</tr>
<tr>
<td style="background-color:#faeeda; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:173px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">70–84 · Good</span></strong></span></span></p>
</td>
<td style="background-color:white; border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:428px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><span style="color:black">Preconditions largely in place, with specific gaps — named in the questions section</span></span></span></p>
</td>
</tr>
<tr>
<td style="background-color:#faece7; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:173px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">50–69 · Average</span></strong></span></span></p>
</td>
<td style="background-color:white; border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:428px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><span style="color:black">Meaningful preconditions missing or weakly evidenced</span></span></span></p>
</td>
</tr>
<tr>
<td style="background-color:#fcebeb; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:173px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">30–49 · Weak</span></strong></span></span></p>
</td>
<td style="background-color:white; border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:428px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><span style="color:black">Several core preconditions absent, or the evidence points against them</span></span></span></p>
</td>
</tr>
<tr>
<td style="background-color:#fcebeb; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:173px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">1–29 · Critical</span></strong></span></span></p>
</td>
<td style="background-color:white; border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:428px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><span style="color:black">Fundamental preconditions are not visible in the evidence</span></span></span></p>
</td>
</tr>
</tbody>
</table>
<p> </p>
<table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:602px">
<tbody>
<tr>
<td style="background-color:#f0f4f8; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:602px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">What we could check. </span></strong><span style="color:black">We verified the company's existence and Murcia base, the founder's identity as a wheelchair user, the 2022 Social-Impact Entrepreneur award, its UCAM HiTech and CEEIM/EOI accelerator support, the reality of the three named competitor products, and the size of the electric-wheelchair market against public sources. The company's revenue plan, margins, lifetime-value figures, cash burn, and cap-table splits rest on its own materials — and two files labelled as financial statements were supplied blank. See the questions section.</span></span></span></p>
</td>
</tr>
</tbody>
</table>
<p> </p>
<table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:602px">
<tbody>
<tr>
<td style="background-color:#f0f4f8; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:602px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">Three answers, one honest note. </span></strong><span style="color:black">The price-fairness score says whether the entry price is supported by sector benchmarks we could find. The AI Score is our read on whether the company has the building blocks in place to reach a stage where a sale or similar event could happen — it is not a probability of success, and even companies with every building block in place fail more often than they succeed, which is why crowdfunding only works as a small part of a diversified portfolio. The returns range is an illustration from named market sources, not a forecast. Where something was not in the pack, it did not lower any score — it appears in the questions list so you can ask the company directly. The listing was reviewed by a licensed crowdfunding platform (Startupxplore) before going live. Nothing here is a recommendation.</span></span></span></p>
</td>
</tr>
</tbody>
</table>
<h1><span style="font-size:14pt"><span style="font-family:Calibri,sans-serif">At a glance</span></span></h1>
<table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:602px">
<tbody>
<tr>
<td style="background-color:#f4f2ec; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:301px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">✅ Three reasons to look closer</span></strong></span></span></p>
</td>
<td style="background-color:#f4f2ec; border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:301px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">⚠️ Three reasons for caution</span></strong></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top; width:301px">
<ul>
<li><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif">Founder-led by a wheelchair user (Juan Antonio Carrasco), so the product is designed from lived experience; award and accelerator support are publicly confirmed.</span></span></li>
<li><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif">Large market, independently corroborated: the global electric-wheelchair market is put at roughly $4.3–9.0B by named reports (Mordor Intelligence, Grand View Research).</span></span></li>
<li><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif">Investor-friendly terms: you would hold ordinary shares of the same class as the founders, with no priority stack ahead of you, plus tag-along and pre-emption rights.</span></span></li>
</ul>
</td>
<td style="border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top; width:301px">
<ul>
<li><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif">Pre-revenue: €0 turnover, 0 units sold, first sales not planned until 2027 (per the company).</span></span></li>
<li><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif">The two files labelled as financial statements (profit-and-loss and balance sheet) were supplied blank — no historical financials were in the pack we reviewed.</span></span></li>
<li><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif">Entrenched competitors — Invacare/Alber, Sunrise Medical and Benoit Systèmes already sell power-assist devices — and CE medical-device certification is not yet achieved.</span></span></li>
</ul>
</td>
</tr>
</tbody>
</table>
<p> </p>
<table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:602px">
<tbody>
<tr>
<td style="background-color:#f4f2ec; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:602px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">Deal terms. </span></strong><span style="color:black">No terms were identified in the reviewed documents that would prevent a crowdfund investor from sharing in the upside. Full mechanics are at the end of this memo.</span></span></span></p>
</td>
</tr>
</tbody>
</table>
<p> </p>
<table cellspacing="0" class="Table" style="border-collapse:collapse; border:none; width:602px">
<tbody>
<tr>
<td style="background-color:#e6f1fb; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top; width:602px">
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif"><strong><span style="color:black">ℹ️ Information, not investment advice. </span></strong><span style="color:black">Capital at risk — you could lose the full amount invested. Full notes are at the end of this memo.</span></span></span></p>
</td>
</tr>
</tbody>
</table>
<h1><span style="font-size:14pt"><span style="font-family:Calibri,sans-serif">🏢 What the company does</span></span></h1>
<p><span style="font-size:10pt"><span style="font-family:Calibri,sans-serif">Avant Devices sells <strong>Explorer One</strong>, a kit that clips onto an ordinary manual wheelchair and turns it into a motorised one. The company reports the drive unit weighs about 8 kg, offers up to around 40 km of range with a double battery, and can be fitted or removed by the user, with interchangeable wheels for city, rural and beach use. Its customers are people with reduced mobility who want a single, transportable device instead of a heavy powered wheelchair, plus the orthopaedic retailers, distributors, associations and rehabilitation centres that would prescribe or sell it. The company plans to earn money three ways: selling the kit (recommended price around €4,500 excl. VAT, or ~€5,900 for an advanced pack), selling accessories, batteries and spare wheels, and — later — recurring maintenance plans and connected services. It operates from Murcia and intends to start commercial sales in Spain in 2027, then Portugal and Western Europe. So far the company reports a working prototype validated in three environments (city, rural, beach), industrial-design protection in progress, and CE medical-device certification underway. This €15k–€215k round (the campaign page shows a €260k total round) is intended to fund CE certification, first production runs, and building a smal…</span></span></p>
Financement participatif (equity crowdfunding)
